Don’t Buy UnitedHealth Group Stock Before Jan. 27

• UnitedHealth’s stock has fallen 34% in 2025.

• Increased visits to doctors and surgeons cut into UnitedHealth’s profits for 2025.

• Investors should watch for company guidance for a projected increase in EPS and a decrease in medical care ratio.

• 10 stocks we like better than UnitedHealth Group ›

UnitedHealth Group (NYSE: UNH) has long been one of the premier health insurance companies in the United States, but it and its stock are not unfamiliar with controversy or volatility. It’s been a rough year so far for UnitedHealth’s stock. Through Dec. 30, the stock is down roughly 34%.

Much of UnitedHealth’s business is stable, but the company is undergoing a transition period. There’s a lot to like about the stock — including how cheap it has become after its recent plunge (a 17 price-to-earnings ratio) — but I recommend waiting until after its Jan. 27 report before making a decision on whether to buy shares.

UnitedHealth is scheduled to release its full-year 2025 results and, arguably more important, its 2026 financial guidance on Jan. 27 before the markets open.

In May 2025, UnitedHealth suspended its profit forecast for the year after having its first quarterly earnings miss in over a decade. The company blamed the miss on rising costs, as people had more doctor visits and surgeries, which meant UnitedHealth had to pay out more in insurance claims than expected. And since the company had no idea how much its costs would increase, it withdrew its profit forecast.

For investors, this was a red flag, leading to its stock price plunge this year. However, on Jan. 27, UnitedHealth has a chance to change the narrative and clear some of the fog and confusion surrounding its profitability and long-term growth prospects.

When UnitedHealth releases its 2026 guidance, investors should look for projections for earnings per share (EPS), medical care ratio (MCR), and operating margin.

UnitedHealth’s 2025 adjusted EPS is projected to come in at at least $16.25, so any 2026 projection that’s only a bit above that would mean proceed with caution.

MCR is the percentage of money UnitedHealth earns from premiums that it spends on medical claims; the lower the better for the company. Ideally, this number is near the mid-80% range.

Operating margin indicates how much money is left after paying doctors and covering other costs. The higher the better, but 4% is a good benchmark to look for. Though this would likely require UnitedHealth to consider price increases, which would surely bring  more scrutiny from politicians and its customers.

So while I would not buy UnitedHealth shares ahead of its Jan. 27 report, if things look good in that release of info, its current valuation could look like a steal for long-term investors.

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $490,703!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,157,689!*

Now, it’s worth noting Stock Advisor’s total average return is 966% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 4, 2026.

Stefon Walters has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Don’t Buy UnitedHealth Group Stock Before Jan. 27 was originally published by The Motley Fool